| pubmed-article:12500242 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0005390 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0029988 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0036992 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0279033 | lld:lifeskim |
| pubmed-article:12500242 | lifeskim:mentions | umls-concept:C0522529 | lld:lifeskim |
| pubmed-article:12500242 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12500242 | pubmed:dateCreated | 2002-12-24 | lld:pubmed |
| pubmed-article:12500242 | pubmed:abstractText | Patients with short bowel syndrome (SBS) have steatorrhea, in part because of bile acid malabsorption that causes decreased bile acid secretion into the duodenum and consequent fat maldigestion. In SBS patients with colon in continuity, luminal calcium forms calcium fatty acid soaps rather than precipitating as insoluble calcium oxalate. Soluble oxalate is hyperabsorbed by the colon leading to hyperoxaluria and an increased risk for renal calcium oxalate stones and deposits. The authors hypothesized that oral ingestion of conjugated bile acids would increase fat absorption and thereby decrease calcium fatty acid soap formation and oxalate hyperabsorption. | lld:pubmed |
| pubmed-article:12500242 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12500242 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12500242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12500242 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12500242 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:12500242 | pubmed:issn | 1523-6838 | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:HofmannAlan... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:EmmettMichael... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:GuirlMichael... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:Santa... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:PorterJack... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:NeimarkSidney... | lld:pubmed |
| pubmed-article:12500242 | pubmed:author | pubmed-author:FordtranJohn... | lld:pubmed |
| pubmed-article:12500242 | pubmed:copyrightInfo | Copyright 2003 by the National Kidney Foundation, Inc. | lld:pubmed |
| pubmed-article:12500242 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12500242 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:12500242 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12500242 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12500242 | pubmed:pagination | 230-7 | lld:pubmed |
| pubmed-article:12500242 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:meshHeading | pubmed-meshheading:12500242... | lld:pubmed |
| pubmed-article:12500242 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12500242 | pubmed:articleTitle | Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome. | lld:pubmed |
| pubmed-article:12500242 | pubmed:affiliation | Department of Internal Medicine, Baylor University Medical Center, Dallas, TX 75246, USA. m.emmett@baylorhealth.edu | lld:pubmed |
| pubmed-article:12500242 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12500242 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12500242 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12500242 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:12500242 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12500242 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12500242 | lld:pubmed |
